DLA, Skadden line up for pharma merger

DLA Piper has scored a role on one of the biggest pharmaceutical deals of the year, lining up alongside Skadden Arps Slate Meagher & Flom in the 6.7bn Dollars(£3.42bn) merger of US biotech suppliers Invitrogen and Applera Corporation. DLA Piper acted for the buyer, Invitrogen, led by San Diego-based relationship partners Jeff Baglio and Jay Rains.